DEVELOPMENT OF DRUG BIOCONJUGATE USING LIGHT SUBUNIT MUSHROOM TYROSINASE (LSMT) FOR ORAL DRUG DELIVERY
Peroral routes for systemic therapy provides ease and convenience of drug administration for patients. However, preparation for peroral therapy provides challenges in terms of manufacturing technology. To ensure the active compound reaches its receptor, the drug must be absorbed into the blood ve...
Saved in:
Main Author: | Diana |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/44433 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
STUDY ANTICANCER ACTIVITY FROM THE LIGHT SUBUNIT OF MUSHROOM TYROSINASE (LSMT) IN BREAST CANCER MODEL MDA-MB-231 CELL LINE AND DEVELOPMENT OF SPHEROID AS TUMOR MODEL
by: Azzahra, Fauzia -
MULTISCALE COMPUTATION ANALYSIS OF INTERACTION BETWEEN MANNOSE AND LIGHT SUBUNIT MUSHROOM TYROSINASE (LSMT) USING MOLECULAR DOCKING AND ONIOM (OUR OWN N-LAYERED INTEGRATED MOLECULAR ORBITALS AND MOLECULAR MECHANICS)
by: Aswin -
EXPLORATION OF BIOLOGICAL ACTIVITIES OF THE LIGHT SUBUNIT OF MUSHROOM TYROSINASE FROM MUSHROOM AGARICUS BISPORUS
by: Nabila, Najwa -
Self-nanoemulsifying drug delivery systems (SNEDDS): An advancement technology for oral drug delivery
by: Boontida Morakul
Published: (2020) -
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
by: Mei, L., et al.
Published: (2014)